Tailong Lei

1.2k total citations
22 papers, 879 citations indexed

About

Tailong Lei is a scholar working on Molecular Biology, Computational Theory and Mathematics and Molecular Medicine. According to data from OpenAlex, Tailong Lei has authored 22 papers receiving a total of 879 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 11 papers in Computational Theory and Mathematics and 8 papers in Molecular Medicine. Recurrent topics in Tailong Lei's work include Computational Drug Discovery Methods (11 papers), Antibiotic Resistance in Bacteria (8 papers) and Protein Structure and Dynamics (4 papers). Tailong Lei is often cited by papers focused on Computational Drug Discovery Methods (11 papers), Antibiotic Resistance in Bacteria (8 papers) and Protein Structure and Dynamics (4 papers). Tailong Lei collaborates with scholars based in China, Macao and United States. Tailong Lei's co-authors include Tingjun Hou, Zhe Wang, Youyong Li, Dan Li, Huiyong Sun, Dongsheng Cao, Yu Kang, Feng Zhu, Zhenhua Wu and Dejun Jiang and has published in prestigious journals such as Bioinformatics, Antimicrobial Agents and Chemotherapy and Physical Chemistry Chemical Physics.

In The Last Decade

Tailong Lei

21 papers receiving 873 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tailong Lei China	13	498	445	126	102	82	22	879
Junjie Ding China	20	397 0.8×	361 0.8×	166 1.3×	101 1.0×	151 1.8×	57	1.3k
Daniel H. Foil United States	18	308 0.6×	276 0.6×	94 0.7×	50 0.5×	80 1.0×	27	797
Rafael Gozalbes Spain	18	423 0.8×	381 0.9×	62 0.5×	245 2.4×	86 1.0×	49	827
Max K. Leong Taiwan	21	286 0.6×	436 1.0×	73 0.6×	195 1.9×	112 1.4×	40	1.2k
Cecilia Bossa Italy	27	864 1.7×	680 1.5×	191 1.5×	201 2.0×	100 1.2×	54	2.1k
Zhi‐Jiang Yao China	10	673 1.4×	672 1.5×	125 1.0×	228 2.2×	151 1.8×	10	1.4k
Nataraj Sekhar Pagadala Canada	7	457 0.9×	617 1.4×	96 0.8×	191 1.9×	150 1.8×	16	1.1k
Vinícius M. Alves United States	23	838 1.7×	587 1.3×	169 1.3×	244 2.4×	120 1.5×	53	1.5k
Chaofeng Lou China	9	559 1.1×	472 1.1×	85 0.7×	263 2.6×	117 1.4×	11	1.2k
Sarah Naomi Bolz Germany	8	300 0.6×	757 1.7×	79 0.6×	249 2.4×	146 1.8×	12	1.4k

Countries citing papers authored by Tailong Lei

Since Specialization

Citations

This map shows the geographic impact of Tailong Lei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tailong Lei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tailong Lei more than expected).

Fields of papers citing papers by Tailong Lei

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tailong Lei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tailong Lei. The network helps show where Tailong Lei may publish in the future.

Co-authorship network of co-authors of Tailong Lei

This figure shows the co-authorship network connecting the top 25 collaborators of Tailong Lei. A scholar is included among the top collaborators of Tailong Lei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tailong Lei. Tailong Lei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Xu, Qingye, Haiyang Liu, Siyuan Yang, et al.. (2025). In vitro activity and resistance mechanisms of sulbactam/durlobactam against Acinetobacter baumannii clinical isolates in China (2019–2020). Clinical Microbiology and Infection. 32(1). 102–109.

Zhang, Xiaofan, Ying Zhang, Tailong Lei, et al.. (2024). Evolution of ceftazidime–avibactam resistance driven by mutations in double-copy bla _KPC-2 to bla _KPC-189 during treatment of ST11 carbapenem-resistant Klebsiella pneumoniae. mSystems. 9(10). e0072224–e0072224. 6 indexed citations

Yao, Yue, Tailong Lei, Junbo Gao, et al.. (2024). Discovery of novel BfmR inhibitors restoring carbapenem susceptibility against carbapenem-resistant Acinetobacter baumannii by structure-based virtual screening and biological evaluation. Emerging Microbes & Infections. 13(1). 2396877–2396877. 1 indexed citations

Wu, Dandan, Shengnan Jiang, Yiyi Chen, et al.. (2024). Role of tcaA, a potential target as a ceftobiprole resistance breaker in MRSA β-lactam resistance. International Journal of Antimicrobial Agents. 64(1). 107185–107185. 1 indexed citations

Li, Xi, Longjie Zhou, Tailong Lei, et al.. (2024). Genomic epidemiology and ceftazidime-avibactam high-level resistance mechanisms of Pseudomonas aeruginosa in China from 2010 to 2022. Emerging Microbes & Infections. 13(1). 2324068–2324068. 7 indexed citations

Chen, Yizhu, Tailong Lei, Keyu Liu, et al.. (2023). Remimazolam attenuates myocardial ischemia-reperfusion injury by inhibiting the NF-ĸB pathway of macrophage inflammation. European Journal of Pharmacology. 965. 176276–176276. 12 indexed citations

Wang, Weiping, Yu Qian, Tailong Lei, et al.. (2023). A Novel CMY Variant Confers Transferable High-Level Resistance to Ceftazidime-Avibactam in Multidrug-Resistant Escherichiacoli. Microbiology Spectrum. 11(2). e0334922–e0334922. 8 indexed citations

Wang, Nanfei, Tailong Lei, Yiwei Zhu, et al.. (2023). Characterization of two novel VIM-type metallo-β-lactamases, VIM-84 and VIM-85, associated with the spread of IncP-2 megaplasmids in Pseudomonas aeruginosa. Microbiology Spectrum. 11(5). e0154423–e0154423. 4 indexed citations

Liu, Xiaochen, Tailong Lei, Linghong Zhang, et al.. (2022). Structural Basis of PER-1-Mediated Cefiderocol Resistance and Synergistic Inhibition of PER-1 by Cefiderocol in Combination with Avibactam or Durlobactam in Acinetobacter baumannii. Antimicrobial Agents and Chemotherapy. 66(12). e0082822–e0082822. 15 indexed citations

10.

Yang, Qing, Fang Li, Tailong Lei, et al.. (2022). A novel KPC-113 variant conferring carbapenem and ceftazidime-avibactam resistance in a multidrug-resistant Pseudomonas aeruginosa isolate. Clinical Microbiology and Infection. 29(3). 387.e7–387.e14. 14 indexed citations

11.

Jiang, Dejun, Tailong Lei, Zhe Wang, et al.. (2020). ADMET evaluation in drug discovery. 20. Prediction of breast cancer resistance protein inhibition through machine learning. Journal of Cheminformatics. 12(1). 16–16. 59 indexed citations

12.

Wu, Zhenhua, Minfeng Zhu, Yu Kang, et al.. (2020). Do we need different machine learning algorithms for QSAR modeling? A comprehensive assessment of 16 machine learning algorithms on 14 QSAR data sets. Briefings in Bioinformatics. 22(4). 122 indexed citations

13.

Shen, Chao, Xuwen Wang, Tailong Lei, et al.. (2019). Importance of Incorporating Protein Flexibility in Molecule Modeling: A Theoretical Study on Type I1/2 NIK Inhibitors. Frontiers in Pharmacology. 10. 345–345. 11 indexed citations

14.

Wu, Zhenhua, Tailong Lei, Chao Shen, et al.. (2019). ADMET Evaluation in Drug Discovery. 19. Reliable Prediction of Human Cytochrome P450 Inhibition Using Artificial Intelligence Approaches. Journal of Chemical Information and Modeling. 59(11). 4587–4601. 101 indexed citations

15.

Chen, Fu, Huiyong Sun, Junmei Wang, et al.. (2018). Assessing the performance of MM/PBSA and MM/GBSA methods. 8. Predicting binding free energies and poses of protein–RNA complexes. RNA. 24(9). 1183–1194. 97 indexed citations

16.

Shen, Chao, Zhe Wang, Xiaojun Yao, et al.. (2018). Comprehensive assessment of nine docking programs on type II kinase inhibitors: prediction accuracy of sampling power, scoring power and screening power. Briefings in Bioinformatics. 21(1). 282–297. 39 indexed citations

17.

Wang, Zhe, Xuwen Wang, Youyong Li, et al.. (2018). farPPI: a webserver for accurate prediction of protein-ligand binding structures for small-molecule PPI inhibitors by MM/PB(GB)SA methods. Bioinformatics. 35(10). 1777–1779. 73 indexed citations

18.

Fu, Weitao, Zhe Wang, Xuwen Wang, et al.. (2018). Reliability of Docking-Based Virtual Screening for GPCR Ligands with Homology Modeled Structures: A Case Study of the Angiotensin II Type I Receptor. ACS Chemical Neuroscience. 10(1). 677–689. 27 indexed citations

19.

Lei, Tailong, Fu Chen, Hui Liu, et al.. (2017). ADMET Evaluation in Drug Discovery. Part 17: Development of Quantitative and Qualitative Prediction Models for Chemical-Induced Respiratory Toxicity. Molecular Pharmaceutics. 14(7). 2407–2421. 63 indexed citations

20.

Lei, Tailong, Youyong Li, Yunlong Song, et al.. (2016). ADMET evaluation in drug discovery: 15. Accurate prediction of rat oral acute toxicity using relevance vector machine and consensus modeling. Journal of Cheminformatics. 8(1). 6–6. 132 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact